CORT Corcept Therapeutics Incorporated
$51.05
▼ 2.11%
38
Value
19
P/E111.30
0
P/B8.36
42
P/S7.13
37
EV/EBITDA-792.29
5
Growth
48
Revenue Growth12.8%
61
EPS Growth-29.6%
41
FCF Growth-27.6%
41
Momentum
64
12-Month Return-27.8%
26
3-Month Return33.1%
100
1-Month Return21.9%
93
RSI (14)68.40
85
50/200 MABearish
30
Profitability
42
ROE7.5%
53
ROA5.9%
42
Gross Margin98.3%
77
Operating Margin-1.1%
19
Net Margin6.2%
36
FCF Yield2.2%
27
Risk
16
Beta0.35
35
60-Day Volatility64.6%
0
QScore Analysis